These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

595 related items for PubMed ID: 16195699

  • 1. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 2. The secretable form of trimeric TRAIL, a potent inducer of apoptosis.
    Kim MH, Billiar TR, Seol DW.
    Biochem Biophys Res Commun; 2004 Sep 03; 321(4):930-5. PubMed ID: 15358116
    [Abstract] [Full Text] [Related]

  • 3. Conditionally replicative adenovirus vector carrying TRAIL gene for enhanced oncolysis of human hepatocellular carcinoma.
    Ye X, Lu Q, Zhao Y, Ren Z, Ren XW, Qiu QH, Tong Y, Liang M, Hu F, Chen HZ.
    Int J Mol Med; 2005 Dec 03; 16(6):1179-84. PubMed ID: 16273304
    [Abstract] [Full Text] [Related]

  • 4. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
    Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B.
    Cancer Res; 2001 Apr 15; 61(8):3330-8. PubMed ID: 11309289
    [Abstract] [Full Text] [Related]

  • 5. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
    Rubinchik S, Yu H, Woraratanadharm J, Voelkel-Johnson C, Norris JS, Dong JY.
    Cancer Gene Ther; 2003 Nov 15; 10(11):814-22. PubMed ID: 14605667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus.
    Griffith TS, Broghammer EL.
    Mol Ther; 2001 Sep 15; 4(3):257-66. PubMed ID: 11545617
    [Abstract] [Full Text] [Related]

  • 10. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
    Wu X, He Y, Falo LD, Hui KM, Huang L.
    Mol Ther; 2001 Mar 15; 3(3):368-74. PubMed ID: 11273779
    [Abstract] [Full Text] [Related]

  • 11. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model.
    Yoo J, Choi S, Hwang KS, Cho WK, Jung CR, Kwon ST, Im DS.
    J Gene Med; 2006 Feb 15; 8(2):163-74. PubMed ID: 16144019
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line.
    Zhang L, Gu J, Lin T, Huang X, Roth JA, Fang B.
    Gene Ther; 2002 Sep 15; 9(18):1262-70. PubMed ID: 12215894
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells.
    Pollack IF, Erff M, Ashkenazi A.
    Clin Cancer Res; 2001 May 15; 7(5):1362-9. PubMed ID: 11350907
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Killing effect of Ad.TERT-TRAIL on tumor cell lines and its mechanism].
    Tang YX, Chen Y, Gu JF, Qi R, Zou WG, Jiang LL, Liu XY.
    Ai Zheng; 2005 May 15; 24(5):536-42. PubMed ID: 15890093
    [Abstract] [Full Text] [Related]

  • 19. Enhanced TRAIL sensitivity by E1A expression in human cancer and normal cell lines: inhibition by adenovirus E1B19K and E3 proteins.
    Hu B, Zhu H, Qiu S, Su Y, Ling W, Xiao W, Qi Y.
    Biochem Biophys Res Commun; 2004 Dec 24; 325(4):1153-62. PubMed ID: 15555548
    [Abstract] [Full Text] [Related]

  • 20. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H, Liu Y, Liu S, Xu R, Zheng D.
    Hepatology; 2005 Dec 24; 42(6):1355-63. PubMed ID: 16317690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.